Volker Laux
Frankfurt Am Main, HE 60596, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Identification of CRTH2 as a New PPARγ-Target Gene in T Cells Suggested CRTH2 Dependent Conversion of Th2 Cells as Therapeutic Concept in COVID-19 Infection.
Journal: ImmunoTargets and therapy
Published: February 09, 2024
Short-term predictor for COVID-19 severity from a longitudinal multi-omics study for practical application in intensive care units.
Journal: Talanta
Published: July 05, 2023
Lecanoric acid mediates anti-proliferative effects by an M phase arrest in colon cancer cells.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 12, 2022
Pharmacological profile of asundexian, a novel, orally bioavailable inhibitor of factor XIa.
Journal: Journal of thrombosis and haemostasis : JTH
Published: November 19, 2021
Characterization of ACE Inhibitors and AT1R Antagonists with Regard to Their Effect on ACE2 Expression and Infection with SARS-CoV-2 Using a Caco-2 Cell Model.
Journal: Life (Basel, Switzerland)
Published: July 06, 2021
Nrf2-A Molecular Target for Sepsis Patients in Critical Care.
Journal: Biomolecules
Published: November 27, 2020
Comprehensive platelet phenotyping supports the role of platelets in the pathogenesis of acute venous thromboembolism - results from clinical observation studies.
Journal: EBioMedicine
Published: February 06, 2020
The dual FXa/thrombin inhibitor SATI prevents fibrin and platelet deposition in hypercoagulant rats.
The dual FXa/thrombin inhibitor SATI prevents fibrin and platelet deposition in hypercoagulant rats.
Journal: Thrombosis research
Published: December 17, 2019
Plasma Kallikrein Contributes to Coagulation in the Absence of Factor XI by Activating Factor IX.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: November 27, 2019
Last Updated: 09/26/2026